Beranda › Kanker Prostat › Pennsylvania › Erie
Uji klinis Kanker Prostat di Erie, PA
5 studi untuk Kanker Prostat mencari peserta di lokasi sekitar Erie (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Menerima pesertaFase 3
- Saint Vincent Hospital, Erie
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Menerima pesertaFase 2
- UPMC Hillman Cancer Center Erie, Erie
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Menerima pesertaFase 3
- UPMC Hillman Cancer Center Erie, Erie
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Menerima pesertaFase 3
- UPMC Hillman Cancer Center Erie, Erie
Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
Menerima pesertaFase 3
- Saint Vincent Hospital, Erie
Uji klinis Kanker Prostat di kota lain
- New York City, NY103 studi
- Houston, TX76 studi
- Los Angeles, CA61 studi
- Boston, MA59 studi
- St. Louis, MO46 studi
- Chicago, IL45 studi
- San Francisco, CA45 studi
- Philadelphia, PA44 studi
- Baltimore, MD43 studi
- Nashville, TN43 studi
- Seattle, WA42 studi
- Washington, DC38 studi
Studi lain di Erie
- Degenerasi Makula10 studi
- Karsinoma Sel Skuamosa Kepala dan Leher6 studi
- Kanker Paru Non-Sel Kecil5 studi
- Kanker Mulut5 studi
- Atrofi Geografis5 studi
- Kanker Paru4 studi
- Kanker Laring4 studi
- Kanker Ginjal (Karsinoma Sel Renal)4 studi
- Kanker Payudara3 studi
- Ambliopia3 studi
- Kanker Endometrium3 studi
- Kanker Hipofaring3 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.